111 related articles for article (PubMed ID: 26410243)
1. Structural and functional impact of missense mutations in TPMT: An integrated computational approach.
Fazel-Najafabadi E; Vahdat Ahar E; Fattahpour S; Sedghi M
Comput Biol Chem; 2015 Dec; 59 Pt A():48-55. PubMed ID: 26410243
[TBL] [Abstract][Full Text] [Related]
2. Structural characteristics determine the cause of the low enzyme activity of two thiopurine S-methyltransferase allelic variants: a biophysical characterization of TPMT*2 and TPMT*5.
Wennerstrand P; Dametto P; Hennig J; Klingstedt T; Skoglund K; Appell ML; Mårtensson LG
Biochemistry; 2012 Jul; 51(30):5912-20. PubMed ID: 22747506
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of novel defective thiopurine S-methyltransferase allelic variants.
Garat A; Cauffiez C; Renault N; Lo-Guidice JM; Allorge D; Chevalier D; Houdret N; Chavatte P; Loriot MA; Gala JL; Broly F
Biochem Pharmacol; 2008 Aug; 76(3):404-15. PubMed ID: 18602085
[TBL] [Abstract][Full Text] [Related]
4. Insight into TPMT(∗)23 mutation mis-folding using molecular dynamics simulation and protein structure analysis.
Larif S; Ben Salem C; Soua Z; Hmouda H; Bouraoui K
J Biomol Struct Dyn; 2013 Oct; 31(10):1066-76. PubMed ID: 23025308
[TBL] [Abstract][Full Text] [Related]
5. Explaining TPMT genotype/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23.
Lindqvist M; Skoglund K; Karlgren A; Söderkvist P; Peterson C; Kidhall I; Almer S
Pharmacogenet Genomics; 2007 Oct; 17(10):891-5. PubMed ID: 17885628
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of allele variation of human thiopurine-S-methyltransferase.
Wu H; Horton JR; Battaile K; Allali-Hassani A; Martin F; Zeng H; Loppnau P; Vedadi M; Bochkarev A; Plotnikov AN; Cheng X
Proteins; 2007 Apr; 67(1):198-208. PubMed ID: 17243178
[TBL] [Abstract][Full Text] [Related]
7. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism.
Szumlanski C; Otterness D; Her C; Lee D; Brandriff B; Kelsell D; Spurr N; Lennard L; Wieben E; Weinshilboum R
DNA Cell Biol; 1996 Jan; 15(1):17-30. PubMed ID: 8561894
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis of protein structure-function relationships: case study of leukocyte elastase (ELA2) missense mutations.
Thusberg J; Vihinen M
Hum Mutat; 2006 Dec; 27(12):1230-43. PubMed ID: 16986121
[TBL] [Abstract][Full Text] [Related]
9. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.
Honchel R; Aksoy IA; Szumlanski C; Wood TC; Otterness DM; Wieben ED; Weinshilboum RM
Mol Pharmacol; 1993 Jun; 43(6):878-87. PubMed ID: 8316220
[TBL] [Abstract][Full Text] [Related]
10. Consequences of binding an S-adenosylmethionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone.
Scheuermann TH; Keeler C; Hodsdon ME
Biochemistry; 2004 Sep; 43(38):12198-209. PubMed ID: 15379558
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional analysis of two rare allelic variants of the thiopurine S-methyltransferase gene, TPMT*16 and TPMT*19.
Hamdan-Khalil R; Gala JL; Allorge D; Lo-Guidice JM; Horsmans Y; Houdret N; Broly F
Biochem Pharmacol; 2005 Feb; 69(3):525-9. PubMed ID: 15652243
[TBL] [Abstract][Full Text] [Related]
12. Tertiary structure of thiopurine methyltransferase from Pseudomonas syringae, a bacterial orthologue of a polymorphic, drug-metabolizing enzyme.
Scheuermann TH; Lolis E; Hodsdon ME
J Mol Biol; 2003 Oct; 333(3):573-85. PubMed ID: 14556746
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of substrate recognition in thiopurine s-methyltransferase.
Peng Y; Feng Q; Wilk D; Adjei AA; Salavaggione OE; Weinshilboum RM; Yee VC
Biochemistry; 2008 Jun; 47(23):6216-25. PubMed ID: 18484748
[TBL] [Abstract][Full Text] [Related]
14. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene.
Appell ML; Wennerstrand P; Peterson C; Hertervig E; Mårtensson LG
Pharmacogenet Genomics; 2010 Nov; 20(11):700-7. PubMed ID: 20881512
[TBL] [Abstract][Full Text] [Related]
17. [In vitro expression and structural analysis of four missense mutations (G247S, E280G, P362T, A434D) of phenylalanine hydroxylase gene].
Song F; Qu Y; Okano Y; Ye Z; Zhang Y; Jin Y; Wang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):1-5. PubMed ID: 18247293
[TBL] [Abstract][Full Text] [Related]
18. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
Zhu Q; Cao Q
Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
[TBL] [Abstract][Full Text] [Related]
19. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
20. Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
Liu YP; Wu HY; Yang X; Xu HQ; Li YC; Shi DC; Huang JF; Huang Q; Fu WL
PLoS One; 2015; 10(3):e0121745. PubMed ID: 25799415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
